T-cell activation (modulation of immune response via T-cell activation)

"Immune system modulation via T-cell activation" refers to a biological process rather than a specific molecular target. It encompasses how various signals—primarily through engagement of the **T-cell receptor (TCR)** with peptide-MHC complexes on antigen-presenting cells and subsequent costimulatory interactions—lead to full **activation** of naïve or memory **T lymphocytes**. This process is central to adaptive immunity; it enables targeted responses against pathogens and tumors but can also drive autoimmunity if dysregulated. Therapeutic strategies often aim at either enhancing this pathway in cancer/immunodeficiency settings or suppressing it in autoimmune diseases. Key druggable molecules within this pathway include surface receptors like **CD28**, **CD3**, and checkpoint regulators such as CTLA4; these are targeted by biologics including monoclonal antibodies and fusion proteins approved for clinical use in several immune-mediated diseases.[1][2][3] > Note: The query describes an immunological mechanism/process rather than a discrete therapeutic target molecule/receptor. For structured data extraction purposes, it should be mapped instead to its key molecular components—most notably "T-cell receptor"—or relevant costimulatory/checkpoint molecules. --- If you need information on specific targets within this pathway—for example "CD28," "CTLA4," or "T-cell receptor" itself—I can provide detailed structured data accordingly.

Other names

T cell activationImmune system modulation by T cellsModulation of immune response via T cells

Inhibition or stimulation of costimulatory signals to modulate T cell activity; Blockade of antigen recognition at the level of peptide-MHC/TCR interaction